No Data
No Data
Renalytix Reveals Total Share Capital and Voting Rights
Express News | Renalytix Receives Written Notification From Nasdaq On August 23, 2024 That Following The Presentation Of Its Operating And Financing Plan, The Co Has Been Granted An Extension Until October 25, 2024 To Regain Compliance With The Minimum Bid Price...
Renalytix AI Secures Nasdaq Listing Extension
Why MIRA Pharmaceuticals Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Renalytix Welcomes New Joint Corporate Broker
Renalytix Board Scraps Potential Takeover Plans
No Data